Literature DB >> 27129378

Do Neuromuscular Alterations Exist for Patients With Acetabular Labral Tears During Function?

Maureen K Dwyer1, Cara L Lewis2, Alfred W Hanmer3, Joseph C McCarthy4.   

Abstract

PURPOSE: To determine if contact forces and electromyography (EMG) muscle amplitudes were altered during the lunge for patients with symptomatic labral tears compared with asymptomatic control subjects.
METHODS: Surface electromyography electrodes were placed over the gluteus medius, gluteus maximus, adductor longus, and rectus femoris muscles of the patients' involved limb and matched limb of asymptomatic controls. Subjects performed 3 trials of the lunge on a clinical force platform. An electrogoniometer tracked knee flexion motion during testing. Average root mean squared EMG muscle amplitudes for each muscle were calculated for the descent and ascent phases of the lunge, represented as a percentage of maximum activity (%MVIC). Peak knee flexion was calculated from the goniometer (°). The dependent variables from the force platform were lunge distance (%height), contact time (seconds), vertical impact force (%BW), and force impulse (%BW*s). Dependent variables were compared between groups using either independent samples t tests or Mann-Whitney U tests. Relations between dependent variables were assessed with Spearman Rho correlation coefficients. The level of significance was set at P ≤ .05.
RESULTS: Twenty-one patients with symptomatic unilateral labral tears (14 females, 7 males) and 17 asymptomatic control subjects (11 females, 6 males) participated in this study. Average gluteus maximus EMG muscle amplitudes were reduced for symptomatic labral patients compared with asymptomatic controls during lunge ascent (51.6 ± 31.1 v 71.7 ± 36.3 [mean difference (MD): 20.1% (-2.4%, 42.6%)], P = .042). Average vertical impact force was reduced (21.8 ± 5.5 v 26.8 ± 7.3 [MD: 5.1%BW (0.84%BW, 9.3%BW)], P = .02) and average contact time (1.8 ± 0.4 v 1.5 ± 0.4 [MD: 0.27 seconds (0.006 seconds, 0.54 seconds)], P = .045) and force impulse (188.4 ± 42.4 v 162.6 ± 33.3 [MD: 25.8%BW*s (0.3%BW*s, 51.4%BW*s)], P = .042) were increased for symptomatic labral patients compared with asymptomatic controls. Vertical impact force was inversely correlated with gluteus medius muscle amplitudes during lunge descent for symptomatic labral patients (r = -0.452, P = .045).
CONCLUSIONS: Our study shows that contact forces and EMG muscle amplitudes are altered during the lunge for patients with symptomatic labral tears. The presence of a relation between muscle amplitudes and contact forces suggests that targeting muscle impairments may restore function in these patients. LEVEL OF EVIDENCE: Level III, case-control study.
Copyright © 2016 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27129378      PMCID: PMC5568890          DOI: 10.1016/j.arthro.2016.03.016

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  28 in total

1.  Acetabular dysplasia: a paradigm of arthroscopic examination of chondral injuries.

Authors:  Joseph C McCarthy; Jo-Ann Lee
Journal:  Clin Orthop Relat Res       Date:  2002-12       Impact factor: 4.176

2.  Anterior hip joint force increases with hip extension, decreased gluteal force, or decreased iliopsoas force.

Authors:  Cara L Lewis; Shirley A Sahrmann; Daniel W Moran
Journal:  J Biomech       Date:  2007-08-17       Impact factor: 2.712

3.  Reliability and interpretation of single leg stance and maximum voluntary isometric contraction methods of electromyography normalization.

Authors:  Marc F Norcross; J Troy Blackburn; Benjamin M Goerger
Journal:  J Electromyogr Kinesiol       Date:  2009-09-09       Impact factor: 2.368

4.  Clinical presentation of patients with tears of the acetabular labrum.

Authors:  R Stephen J Burnett; Gregory J Della Rocca; Heidi Prather; Madelyn Curry; William J Maloney; John C Clohisy
Journal:  J Bone Joint Surg Am       Date:  2006-07       Impact factor: 5.284

5.  The Development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33).

Authors:  Nicholas G H Mohtadi; Damian R Griffin; M Elizabeth Pedersen; Denise Chan; Marc R Safran; Nicholas Parsons; Jon K Sekiya; Bryan T Kelly; Jason R Werle; Michael Leunig; Joseph C McCarthy; Hal D Martin; J W Thomas Byrd; Marc J Philippon; Robroy L Martin; Carlos A Guanche; John C Clohisy; Thomas G Sampson; Mininder S Kocher; Christopher M Larson
Journal:  Arthroscopy       Date:  2012-05       Impact factor: 4.772

Review 6.  The outcome of hip arthroscopy in Australian football league players: a review of 27 hips.

Authors:  Parminder J Singh; John M O'Donnell
Journal:  Arthroscopy       Date:  2010-03-31       Impact factor: 4.772

7.  Femoroacetabular impingement: normal values of the quantitative morphometric parameters in asymptomatic hips.

Authors:  Marianne Lepage-Saucier; Cécile Thiéry; Ahmed Larbi; Frédéric E Lecouvet; Bruno C Vande Berg; Patrick Omoumi
Journal:  Eur Radiol       Date:  2014-04-27       Impact factor: 5.315

8.  Hip arthroscopy in athletes: 10-year follow-up.

Authors:  J W Thomas Byrd; Kay S Jones
Journal:  Am J Sports Med       Date:  2009-08-14       Impact factor: 6.202

Review 9.  Hip arthroscopy: current indications, treatment options, and management issues.

Authors:  Bryan T Kelly; Riley J Williams; Marc J Philippon
Journal:  Am J Sports Med       Date:  2003 Nov-Dec       Impact factor: 6.202

10.  Hip disability and osteoarthritis outcome score (HOOS)--validity and responsiveness in total hip replacement.

Authors:  Anna K Nilsdotter; L Stefan Lohmander; Maria Klässbo; Ewa M Roos
Journal:  BMC Musculoskelet Disord       Date:  2003-05-30       Impact factor: 2.362

View more
  1 in total

1.  HIP MUSCLE INHIBITION AFTER HIP ARTHROSCOPY: A ROLE FOR NEUROMUSCULAR ELECTRICAL STIMULATION.

Authors:  Allison M Mumbleau; Nathan D Schilaty; Timothy E Hewett
Journal:  Int J Sports Phys Ther       Date:  2020-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.